Two healthcare professionals looking at a tablet

Reduce Complications

Exclusive innovations to help you provide the best possible care for your cardiac device patients.

Exclusive Innovations 

Micra VR on a navy blue background

63%

Reduction in
Major Complications1
Micra™ VR

Learn about micra
Attain Stability Quad on a navy blue background

81%

Reduction in
LV Lead Dislodgements
during Implant2,3
Attain Stability Quad™ LV Lead

Learn About ASQ
TYRX Absorbable Antibacterial Envelope on a navy blue background

61%

Reduction in
Device Pocket Infections4
TYRX™ Absorbable
Antibacterial Envelope

learn about TYRX

reduce ER and hospital visits 

Reduce  AF-related ER Visits

68% fewer with Reactive ATP™ algorithm5

Learn about reactive ATP

Reduce AF-related  Hospitalizations

  • 42% fewer with Reactive ATP algorithm5
  • 58% fewer with AdaptivCRT™ algorithm6

Learn about ADAPTIVCRT

Reduce 30-day HF Readmissions

59% reduction in a patient’s odds of a 30-day readmission (AdaptivCRT algorithm)7

EDUCATION AND ADDITIONAL RESOURCES

Education AND TRAINING

View our education and training material for more information. 

Visit Medtronic Academy

Medtronic 24-Hour support

1-800-505-4636

Follow Us On Social Media

Stay up to date with new products, innovative stories, and events:

Follow Us On Social Media

Stay up to date with new products, innovative stories, and events:

References

1

El-Chami MF, Al-Samadi F, Clementy N, et al. Updated performance of the Micra transcatheter pacemaker in the real world setting: A comparison to the investigational study and a transvenous historical control. Heart Rhythm. December 2018;15(12):1800-1807.

2

Crossley GH, Biffi M, Johnson B, et al. Performance of a novel left ventricular lead with short bipolar spacing for cardiac resynchronization therapy: primary results of the Attain Performa quadripolar left ventricular lead study. Heart Rhythm. April 2015;12(4):751-758.

3

Crossley GH, et al. Performance of a Novel Active Fixation Quadripolar Left Ventricular Lead for Cardiac Resynchronization Therapy. Presented at HRS 2019 (poster). 

4

Tarakji KG, Mittal S, Kennergren C, et al. Antibacterial Envelope to Prevent Cardiac Implantable Device Infection. N Engl J Med. May 16, 2019;380(20):1895-1905.

5

Boriani G, Manolis AS, Tukkie R, et al. Effects of enhanced pacing modalities on health care resource utilization and costs in bradycardia patients: An analysis of the randomized MINERVA trial. Heart Rhythm. June 2015;12(6):1192-1200.

6

Lemke B, et al. Atrial Fibrillation Resource Use with an Adaptive Device Algorithm. Presented at CardioStim 2014.

7

Starling RC, Krum H, Bril S, et al. Impact of a Novel Adaptive Optimization Algorithm on 30-Day Readmissions: Evidence From the Adaptive CRT Trial. JACC Heart Fail. July 2015;3(7):565-572.